Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 17, 2023

Safety and Effectiveness of Metformin Plus Lifestyle Intervention vs Lifestyle Intervention Alone in Preventing Diabetes Progression in a Chinese Population With Impaired Glucose Regulation

The Lancet Diabetes & Endocrinology


Additional Info

The Lancet Diabetes & Endocrinology
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial
Lancet Diabetes Endocrinol 2023 Jul 03;[EPub Ahead of Print], L Zhang, Y Zhang, S Shen, X Wang, L Dong, Q Li, W Ren, Y Li, J Bai, Q Gong, H Kuang, L Qi, Q Lu, W Cheng, Y Liu, S Yan, D Wu, H Fang, F Hou, Y Wang, Z Yang, X Lian, J Du, N Sun, L Ji, G Li

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading